Cohort study of treatment strategy for low risk HER2 positive breast cancer based on response-guided therapy and shared decision making
Not Applicable
Recruiting
- Conditions
- HER2 positive breast cancer
- Registration Number
- JPRN-UMIN000050326
- Lead Sponsor
- Eiichi Shiba,the Department of Breast and Endocrine Surgery, Osaka Breast Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) Concurrent bilateral breast cancer, multiple ipsilateral breast cancers of different subtypes 2) History of breast cancer, active overlapping cancers, history of allergies that would result in protocol interruption 3) History of serious cardiac disease (heart failure, myocardial infarction, ischemic disease, vascular disease requiring treatment) 4) Difficulty in continuing hospital visits due to physical inactivity 5) Complicated mental illness or psychiatric symptoms that make participation in the study difficult 6) In case the attending physician determines that the subject is not suitable for participation in the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method